196 related articles for article (PubMed ID: 10551266)
1. Structural and functional characterization of Kv6.2 a new gamma-subunit of voltage-gated potassium channel.
Zhu XR; Netzer R; Böhlke K; Liu Q; Pongs O
Recept Channels; 1999; 6(5):337-50. PubMed ID: 10551266
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and characterization of Kv6.3, a novel modulatory subunit for voltage-gated K(+) channel Kv2.1.
Sano Y; Mochizuki S; Miyake A; Kitada C; Inamura K; Yokoi H; Nozawa K; Matsushime H; Furuichi K
FEBS Lett; 2002 Feb; 512(1-3):230-4. PubMed ID: 11852086
[TBL] [Abstract][Full Text] [Related]
3. A new K+ channel beta subunit to specifically enhance Kv2.2 (CDRK) expression.
Fink M; Duprat F; Lesage F; Heurteaux C; Romey G; Barhanin J; Lazdunski M
J Biol Chem; 1996 Oct; 271(42):26341-8. PubMed ID: 8824288
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and functional characterization of a novel delayed rectifier potassium channel from channel catfish (Ictalurus punctatus): expression in taste buds.
Kang J; Teeter JH; Brazier SP; Nguyen ND; Chang CC; Puchalski RB
J Neurochem; 2001 Mar; 76(5):1465-74. PubMed ID: 11238731
[TBL] [Abstract][Full Text] [Related]
5. Mutation of histidine 105 in the T1 domain of the potassium channel Kv2.1 disrupts heteromerization with Kv6.3 and Kv6.4.
Mederos Y Schnitzler M; Rinné S; Skrobek L; Renigunta V; Schlichthörl G; Derst C; Gudermann T; Daut J; Preisig-Müller R
J Biol Chem; 2009 Feb; 284(7):4695-704. PubMed ID: 19074135
[TBL] [Abstract][Full Text] [Related]
6. Subunit assembly and domain analysis of electrically silent K+ channel alpha-subunits of the rat Kv9 subfamily.
Stocker M; Hellwig M; Kerschensteiner D
J Neurochem; 1999 Apr; 72(4):1725-34. PubMed ID: 10098883
[TBL] [Abstract][Full Text] [Related]
7. Structural determinants of the regulation of the voltage-gated potassium channel Kv2.1 by the modulatory α-subunit Kv9.3.
Kerschensteiner D; Monje F; Stocker M
J Biol Chem; 2003 May; 278(20):18154-61. PubMed ID: 12642579
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human Kv4.2 mediating a rapidly-inactivating transient voltage-sensitive K+ current.
Zhu XR; Wulf A; Schwarz M; Isbrandt D; Pongs O
Recept Channels; 1999; 6(5):387-400. PubMed ID: 10551270
[TBL] [Abstract][Full Text] [Related]
9. Heteromultimeric potassium channels formed by members of the Kv2 subfamily.
Blaine JT; Ribera AB
J Neurosci; 1998 Dec; 18(23):9585-93. PubMed ID: 9822719
[TBL] [Abstract][Full Text] [Related]
10. The subfamily-specific interaction between Kv2.1 and Kv6.4 subunits is determined by interactions between the N- and C-termini.
Bocksteins E; Mayeur E; Van Tilborg A; Regnier G; Timmermans JP; Snyders DJ
PLoS One; 2014; 9(6):e98960. PubMed ID: 24901643
[TBL] [Abstract][Full Text] [Related]
11. Modulation of potassium channel gating by coexpression of Kv2.1 with regulatory Kv5.1 or Kv6.1 alpha-subunits.
Kramer JW; Post MA; Brown AM; Kirsch GE
Am J Physiol; 1998 Jun; 274(6):C1501-10. PubMed ID: 9696692
[TBL] [Abstract][Full Text] [Related]
12. Modification of delayed rectifier potassium currents by the Kv9.1 potassium channel subunit.
Richardson FC; Kaczmarek LK
Hear Res; 2000 Sep; 147(1-2):21-30. PubMed ID: 10962170
[TBL] [Abstract][Full Text] [Related]
13. Kv2.1 and electrically silent Kv6.1 potassium channel subunits combine and express a novel current.
Post MA; Kirsch GE; Brown AM
FEBS Lett; 1996 Dec; 399(1-2):177-82. PubMed ID: 8980147
[TBL] [Abstract][Full Text] [Related]
14. Auxiliary KCNE subunits modulate both homotetrameric Kv2.1 and heterotetrameric Kv2.1/Kv6.4 channels.
David JP; Stas JI; Schmitt N; Bocksteins E
Sci Rep; 2015 Aug; 5():12813. PubMed ID: 26242757
[TBL] [Abstract][Full Text] [Related]
15. Obligatory heterotetramerization of three previously uncharacterized Kv channel alpha-subunits identified in the human genome.
Ottschytsch N; Raes A; Van Hoorick D; Snyders DJ
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):7986-91. PubMed ID: 12060745
[TBL] [Abstract][Full Text] [Related]
16. New modulatory alpha subunits for mammalian Shab K+ channels.
Salinas M; Duprat F; Heurteaux C; Hugnot JP; Lazdunski M
J Biol Chem; 1997 Sep; 272(39):24371-9. PubMed ID: 9305895
[TBL] [Abstract][Full Text] [Related]
17. Determining the correct stoichiometry of Kv2.1/Kv6.4 heterotetramers, functional in multiple stoichiometrical configurations.
Möller L; Regnier G; Labro AJ; Blunck R; Snyders DJ
Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9365-9376. PubMed ID: 32284408
[TBL] [Abstract][Full Text] [Related]
18. Molecular site of action of the antiarrhythmic drug propafenone at the voltage-operated potassium channel Kv2.1.
Madeja M; Leicher T; Friederich P; Punke MA; Haverkamp W; Musshoff U; Breithardt G; Speckmann EJ
Mol Pharmacol; 2003 Mar; 63(3):547-56. PubMed ID: 12606761
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Closed-State Inactivation in Kv2.1/Kv6.4 Heterotetramers as Mechanism for 4-AP Induced Potentiation.
Stas JI; Bocksteins E; Labro AJ; Snyders DJ
PLoS One; 2015; 10(10):e0141349. PubMed ID: 26505474
[TBL] [Abstract][Full Text] [Related]
20. Expression of voltage-gated potassium channels in human and rhesus pancreatic islets.
Yan L; Figueroa DJ; Austin CP; Liu Y; Bugianesi RM; Slaughter RS; Kaczorowski GJ; Kohler MG
Diabetes; 2004 Mar; 53(3):597-607. PubMed ID: 14988243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
